I have worked with Reaction Biology Europe and Reaction Biology Corp. for more than 5 years on several interesting projects. These have ranged from routine enzyme screening to more complex kinome-scan and in-cell target engagement work. The results of these endeavours have led to series of top tier publications. This coupled with exceptional customer service means I have no hesitation to recommend Reaction Biology Corp. and Reaction Biology Europe as research partners.




PREDiCT: Tumor Models
Join us to learn about innovative tumor models for oncology drug discovery.

Drug Discovery Chemistry
Learn about strategies for small molecule compound development in the targeted approach.

AACR Annual Meeting
Get up to date on the latest discoveries in cancer research.

RSC/SCI symposium on kinase inhibitor design
Join us to learn about new approaches and case studies in the kinase drug discovery field.

European Oncology Partnering Convention
Expand your network and meet new people in the oncology field.

Immuno Series UK
Join us at our first in-person meeting this year to explore our immuno-oncology platform.

Discovery Series UK
An in-person event to meet our scientists heading our biophysical and KRAS-related service units…
COVID-19 /SARS-CoV2 update
Dear customers,
all Reaction Biology research facilities are and remain fully operational under safe work environment guidelines. Our business will not close due to lockdown restrictions in Europe. Our sales staff and business development team are happy to discuss any project with you. Please reach out!
Cooperation with 4HF Biotec to provide new Bioinformatic Cell Service
In cooperation with the bioinformatics firm 4HF Biotec, we announce the offering of a combination of the ProLiFiler cell panel screening service with 4HF‘s bioinformatic evaluation of the drug‘s profile.
ProQinase is now Reaction Biology Europe
ProQinase rebranding into Reaction Biology Europe GmbH was performed completing the process of acquiring ProQinase. As this only represents a change of name, all contracts with former ProQinase remain valid and binding. All ProQinase products and services are continued and available within the Reaction Biology portfolio.